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A bstract
Host im m une response has been considered as an  
im portant d isease-m odifying factor of periodon -
titis , how ever, w hich  im m une cell(s) or factor(s) 
are involved in the destruction of periodontium  re -
m ains unclear. Previously, we reported that osteo -
clastogenesis is enhanced by activated B cells but 
suppressed by activated CD8+ T cells. W e present 
new data that B  cells activated in the presence of 
Th1 cytokines inh ibit osteoclastogenesis. Purified  
m urine B  cells  w ere activated  w ith  anti-IgD  m A b, 
IL-4, and anti-C D 40 m A b, in  the absence (B Th2) or 
presence of Th1 cytokines, either IL-2 (B IL-2) or 
IFN-γ (B IFN-γ). Each activated B  cell population w as 
co-cu ltured w ith  R A W 264.7 cells  in  the presence 
o f s o lu b le  re c e p to r a c tiv a to r o f N F -κB  ligand  
(sR A N KL), and the effect on osteoclastic d ifferen -
tiation w as evaluated. W hile B Th2 increased osteo -
clastogenesis, B IL-2 and B IFN-γ suppressed it pro -
foundly. To  verify  the m ediating m olecule(s), w e  
analyzed cytokine profiles of the activated B cells. 
C o m p a re d  to  B T h 2, B IL -2 e x p re s s e d  in c re a s e d  
am o u n t of IFN -γ and B IFN-γ expressed decreased  
am ounts of IL-4, IL-5, and IL -10. IFN -γ w as a key  
negative regulator o f osteoclastic d ifferentiation, 
and m ediated the inhibition by B IL-2. These results  
suggest that Th1 cytokines m ay have new  im -
portant ro les in  resistance to  periodontitis, acting  
d irectly  on  osteoclasts or indirectly  through B  
cells.
Keywords: B lymphocyte subsets; cytokines; inter-
feron type II; interleukin-2; osteoclasts; Th1 cells
In troduction
Although microbial plaque is a primary etiologic agent 
responsible for periodontitis, host immune response 
has long been considered as an important disease- 
modifying factor. Considering the protective function 
of immune response, to determine which immune 
cell(s) or factor(s) are involved in the destruction of 
periodontium rather than protection is important to 
predict disease course and plan treatment. People 
with defects in neutrophil function demonstrated that 
neutrophil has a pivotal role in the protection from 
periodontitis (Cianciola et al., 1977; Clark et al., 1977; 
Anderson et al., 1985). Chronically inflamed period-
ontal tissues are infiltrated densely with lymphocytes 
as well as phagocytic leukocytes. To understand the 
role of the infiltrated lymphocytes in the pathogenesis 
of periodontitis, many investigators studied the num-
ber and proportion of lymphocyte populations and 
established a concept that the change from a stable 
to a progressive lesion was associated with the 
increased infiltration of B cells and plasma cells (Mac-
kler et al., 1977; Seymour et al., 1979; Malberg et 
al., 1992). However, the role of B cells in the path-
ogenesis of periodontitis has been controversial: while 
some insisted that plasma cell predominance per se 
causes periodontal bone loss (Seymour, 1991; Kinane, 
2000), some insisted that periodontal destruction does 
not result from the conversion of a predominantly T 
cell to a predominantly B cell lesion, but rather from 
episodes of acute inflammation (Page, 1986).
  To clarify this issue, we studied the effect of each 
activated lymphocyte subset on osteoclast differen-
tiation and activation in vitro and reported previously 
that osteoclastogenesis is enhanced by activated B 
cells but suppressed by activated CD8+ T cells (Choi 
et al., 2001). However, we subsequently observed 
that B cells could also suppress osteoclastogenesis 
depending on the activation protocol used. In this study, 
we demonstrated that B cells activated in the pre-
sence of Th1 cytokines suppressed osteoclastogene-
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sis. In addition, we studied cytokine profiles of B cells 
activated in the absence or presence of Th1 cyto-
kines, and have shown that IFN-γ was a key negative 
regulator of osteoclastic differentiation and mediated 
the inhibition of osteoclastogenesis by B cells acti-
vated in the presence of IL-2.
M ateria ls and M ethods
M ice and reagents
Four to six week-old C57BL/6 female mice (Han-Lim 
Laboratory Animal Co. Kyung-gi, Korea), were used 
for all experiments. Recombinant murine (rm) sRANKL, 
rmIFN-γ, rmIL-2, and rmIL-10 were purchased from 
Peprotech (London, UK). Other cytokines including 
recombinant human (rh) TGF-β, rmIL-4, rmIL-13, and 
rmTNF-α were purchased from R&D systems (Min-
neapolis, MN). All monoclonal antibodies were pur-
chased from BD PharMingen (San Diego, CA).
A ctivation of B  cells
Mononuclear leukocytes were isolated from spleno-
cytes by Ficoll separation, and then subjected to T- 
cell depletion using anti-CD3 Ab-conjugated Dyna-
beads (Dynal, Lake Success, NY). The purified B 
cells were re-suspended in α-MEM complete medium 
(10% fetal bovine serum, 2 mM glutamine, penicillin, 
streptomycin) at 2×106 cells/ml and activated for 2 
days with 1 mg/ml anti-IgD Ab clone 217-170, 0.2 
mg/ml anti-CD 40 Ab clone HM40-3, and 20 IU/ml 
rmIL-4, in the absence or presence of Th1 cytokines, 
either 100 IU/ml rhIL-2 (Chiron Therapeutics, Emery-
ville, CA) or 50 ng/ml rmIFN-γ. We designate the B 
cells activated by three different protocols BTh2, BIL-2, 
and BIFN-γ, respectively. Following B cell-specific acti-
vation, few granulocytes survived and most mono-
cytes remained attached to the culture plate. The puri-
ties of the activated B cells were confirmed by flow 
cytometry before co-culture and they were between 
95-98%.
In  vitro  osteoclastogenesis and co-culture
w ith  activated B  cells
Murine monocyte cell line RAW264.7 was purchased 
from ATCC (Bethesda, MD). After expansion, cells at 
passage 4 or 5 were kept as frozen vials and freshly 
thawed cells were used for all experiments. For tart-
rate resistant alkaline phosphatase (TRAP) stain and 
TRAP enzyme activity assay, RAW264.7 cells were 
plated into 96-well plates at 2,500 cells/0.15 ml/well 
in α-MEM complete medium with murine soluble RANKL 
(20 ng/ml). On day 2, the medium with sRANKL was 
replaced with fresh one and co-cultured with activated 
B cells (5×105 cells/well) for another 3 days. For re-
sorption assay, RAW264.7 cells were plated in 48- 
well Osteoclast Activity Assay System plates (OAAS; 
Oscotec, Korea) at 4,500 cells/0.3 ml/well in α-MEM 
complete medium with murine soluble RANKL (20 
ng/ml) for 2 days, and then co-cultured with activated 
B cells (106 cells/well) for another 6 days, replacing 
them once with new activated B cells on day 5. After 
co-culture, the supernatants were saved and kept in 
-70oC for ELISA assay. For neutralization of IFN-γ, 
various amounts of anti-INF-γ mAb, clone H22 were 
added with BIL-2 cells from day 2 to 5.
TR A P activity assay
After wash, the entire adherent cells in each well 
were lysed with 50 µl RIPA buffer. TRAP activity was 
measured by the conversion of α-naphthyl phosphate 
(2.5 mM; Sigma) to α-naphthol in the presence of 25 
mM L-tartrate solution (Sigma). Absorbance was 
measured at 405 nm using a microplate reader.
TR A P stain
After wash, cells were fixed with 3% formaldehyde in 
acetone for 30 s. Cells were stained for TRAP using 
a leukocyte acid phosphatase staining kit (No. 387, 
Sigma). TRAP+ cells with three or more nuclei were 
regarded as osteoclasts and counted under an in-
verted-phase contrast microscope.
R esorption assay
After termination of culture, all remaining cells on the 
OAAS plates were lyzed using 1 M NaOH. The image 
(×40) of an entire well was captured, and resorbed 
area was measured using a computer-assisted image 
analyzer (ImagePro v4.0; Media Cybernetics, Bethes-
da, MD).
R everse transcription  (R T)-PC R
Total RNA was extracted from B cells that were 
activated for 2 days with three different protocols. 
Total RNA (1 µg) was subjected to RT with (dT)16 
and 1 µl of Superscript II enzyme (GibcoBRL, NY) 
in 20 ml reaction mix. After 1 h at 42oC, 1 µl and 
serially diluted samples (1/5 and 1/25) were subjected 
to PCR in cycling conditions: 94oC, 20 s; 60oC, 30 
s; 72oC, 1 min for 35 cycles. Actin gene amplified 
for 25 cycles served a control for RNA input. Primer 
sequences used are listed in Table 1.
ELISA
The amounts of IL-2, IL-4, IL-10, and IFN-γ secreted 
into media during co-culture with activated B cells, 
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were measured using ELISA kits from R&D systems. 
Cytokines in the media from the culture of osteoclasts 
alone were also measured.
Statistics
Unless stated otherwise, Student t-test was performed 
to compare experimental wells with control wells that 
were cultured with sRANKL alone.
R esu lts
B  cells activated  in  the presence of Th1
cytokines suppress osteoclastogenesis
Previously, we reported that activated B cells enhance 
osteoclastogenesis (Choi et al., 2001). However, we 
subsequently observed that the activated B cells 
could have different effects on osteoclastic differen-
tiation depending on the activation protocol: while B 
cells activated with PWM following T cell depletion 
enhanced osteoclastogenesis, B cells activated in the 
presence of T cells followed by T cell depletion sup-
pressed it (data not shown). These observations sug-
gested that some factor(s) from T cells changed the 
phenotype of the activated B cells, thereby effects on 
osteoclastogenesis. Since the suppressive effect was 
further aggravated by addition of IL-2, we hypothe-
sized that Th1 cells as well as Th2 cells might have 
a role in B cell activation. The exact mechanism of 
signaling or activation by PWM is not known, there-
fore, we modified our activation protocol to test our 
hypothesis. B cells activated with anti-IgD Ab, anti-CD 
40 Ab, and IL-4, simulated Th2 cell-dependent B cell 
activation (BTh2). To simulate B cell activation under 
the influence of Th1 cells as well as Th2 cells, 
purified B cells were incubated with anti-IgD Ab, 
anti-CD 40 Ab, and IL-4 plus either IL-2 (BIL-2) or 
IFN-γ (BIFN-γ). For in vitro osteoclastogenesis, we 
adopted a well-established model system using RAW-
264.7 cells that comprise a pure population of 
monocytic lineage and easily differentiate into osteo-
clasts after 5 to 6 days in culture in the presence 
of sRANKL (Hsu et al., 1999; Shevde et al., 2000). 
On day 2 when we started co-culture with activated 
B cells, all cells still were mononuclear and less than 
20% were TRAP+. Following co-culture, the influence 
of activated B cells on the osteoclast differentiation 
was evaluated by the formation of TRAP+ multinuclear 
cell (MNC), TRAP activity, and resorption of coated 
minerals. All three assays showed that BTh2 increased 
osteoclastogenesis but either BIL-2 or BIFN-γ suppressed 
it substantially (Figure 1).
The phenotypes of activated  B  cells
These results suggested that the presence of Th1 
cytokines during activation altered the phenotypes of 
activated B cells. B cells secrete various cytokines 
that affect osteoclastogenesis positively or negatively. 
We studied the expression profile of pro- and anti- 
inflammatory, Th1, and Th2 cytokines as well as 
RANKL, osteoprotegerin (OPG) and RANK using 
semi-quantitative RT-PCR (Figure 2A). First, there 
was no difference in the expression of the key reg-
ulators of osteoclastogenesis, RANKL and OPG: all 
expressed high levels of RANKL but no OPG. The 
expression of RANK was not observed, either. All 
three types of B cells expressed similar levels of a 
pro-inflammatory cytokine, TNF-α, but an anti-inflam-
matory cytokine, TGF-β in different levels, being BIFN-γ
＞ BIL-2 ＞ BTh2. We had expected that the presence 
of Th1 cytokines during activation might skew the 
cytokine profile toward Th1, but such a pattern was 
T a b le  1 . Primer sequences used in RT-PCR.
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not observed clearly. In general, all three types of B 
cells expressed both Th1 and Th2 cytokines. How-
ever, increased expression of IFN-γ by BIL-2 and de-
creased expression of Th2 cytokines including IL-4, 
IL-5, and IL-10 by BIFN-γ were noted. Since IL-4, IL-2, 
and IFN-γ were added in saturating levels during 
activation, B cells might have turned off their own 
synthesis, producing artificially low mRNA results by 
RT-PCR. Therefore, we also measured the amounts 
of the cytokines secreted into supernatants upon 
co-culture by ELISA. As shown in Figure 2B, the 
results by ELISA quite well reflected the results by 
RT-PCR: BIL-2 expressed a high level of IFN-γ and 
BIFN-γ expressed the lowest levels of IL-4 and IL-10.
IFN -γ is  a  key negative regulator of osteoclast
differentiation  and m ediates the suppressive
effect o f B IL-2 cells
Interestingly, TRAP- MNCs, rather than TRAP+ MNCs, 
were often observed upon co-culture with BIL-2 cells 
(Figure 3A). These TRAP- MNCs did not have actin 
rings at the periphery (data not shown), and they 
phagocytosed beads (Figure 3A), a characteristic of 
giant cells. IFN-γ is known to induce the formation of 
giant cells and indeed as small as 1 ng/ml of IFN-γ 
could convert the developing osteoclasts into giant 
cells (Figure 3B).
  These results indicated that IFN-γ must be a major 
factor mediating the suppressive effect by BIL-2, and 
it was clearly confirmed by the use of anti-IFN-γ 
neutralizing mAb (Figure 4). In the control experiment 
without BIL-2, the anti-IFN-γ mAb did not have much 
effect on either TRAP activity or formation of TRAP+ 
MNC. In contrast, upon co-culture with BIL-2, the anti- 
IFN-γ mAb reversed the suppressive effect of BIL-2 
completely (TRAP+ MNC) and increased the level of 
TRAP activity even higher than that of control. It sug-
gested that IFN-γ is a key suppressor secreted from 
BIL-2 and with the function of IFN-γ blocked, BIL-2 may 
also enhance osteoclastogenesis.
  BIL-2 express cytokines that are known to antago-
nize IFN-γ mediated activation of macrophage: IL-4, 
IL-13, IL-10, and TGF-β (Gazzinelli et al., 1992; 
Hausmann et al., 1994; Paludan et al., 1997; Palu-
dan et al., 1998). We tested if these cytokines can 
antagonize the effect of IFN-γ on osteoclasts, too. In 
addition, we tested TNF-α that induces high ex-
pression of tumor necrosis factor receptor-associated 
factor 6 (TRAF6) since IFN-γ inhibits osteoclastogene-
sis by degrading TRAF6 (Takayanagi et al., 2000; 
Zhang et al., 2001). 2 ng/ml IFN-γ decreased the 
TRAP activity and TRAP+ MNC about 50%, a similar 
level obtained by co-culture with BIL-2. Therefore, in-
stead of co-culture with BIL-2, 2 ng/ml IFN-γ plus 
various cytokines were added from day 2 to day 5 
during osteoclastogenesis using RAW264.7 cells. 
Among tested cytokines (TNF-α, IL-4, IL-13, IL-10, 
and TGF-β), only TNF-α showed a slight antagonistic 
effect but it never antagonized the effect of IFN-γ 
completely even at high concentration (Figure 5).
F ig u re  1 . B cells activated in the presence of Th1 cytokines inhibit osteoclastogenesis. RAW264.7 cells plated in 96-well or 48-well OAAS plates
were cultured in the presence of 20 ng/ml sRANKL. Co-culture with activated B cells was performed from day 2 to 5 at 5×105 cells/well in
96-well plate (TRAP stain and TRAP activity assay) or from day 2 to 8 at 106 cells/well in 48-well OAAS plates. Resorption area was expressed
as %  to control wells in which RAW264.7 cells were cultured without co-culture with B cells. Each column represents the mean and SEM of
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D iscussion
In this study, we have demonstrated that cytokine en-
vironment during B cell activation can change the 
phenotype of the activated cells. Recently, it was 
shown that B cells co-cultured with Th1 cells or Th2 
cells differentiated into two populations of effector B 
cells that secrete Th1 cytokines and Th2 cytokines, 
respectively (Harris et al., 2000). Although such a 
clear polarized pattern was not observed, BIL-2 ex-
pressed an increased level of IFN-γ and BIFN-γ expres-
sed decreased levels of Th2 cytokines including IL-4, 
IL-5, and IL-10 compared with BTh2 (Figure 2A and 
2B). Several cytokines and surface molecules, rather 
than a single cytokine, may be required to induce 
completely polarized effector cells. In addition, acti-
vated B cells may have heterogeneous phenotypes 
between two completely polarized types depending on 
their micro-environment during activation. B cells first 
encounter Ag and undergo initial activation in the T 
cell zone of peripheral lymphoid organs, where the 
Th1/Th2 cytokine balance in the vicinity of B cells 
during activation is known to affect the phenotypes 
of activated B cells.
  BTh2 expressed pro-osteolytic factors including RANKL, 


















































F ig u re  2 . The cytokine profiles of B cells activated with various 
protocols. (A) The expression of pro-inflammatory, anti-inflammatory, 
Th1, and Th2 cytokines as well as RANKL and OPG in the activated 
B cells were evaluated by semi-quantitative RT-PCR. (B) Th1 and 
Th2 cytokines secreted into supernatants in the co-culture system 
were measured by ELISA. Supernatants from control wells with 
RAW264.7 cells alone were also included. Each column represents 
the mean and SEM of triplicate wells. The data shown are a 
representative of four experiments with very similar patterns.
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F ig u re  3 . Co-culture with BIL-2 or IFN-γ induced formation of giant cells. A. RAW 264.7 cells were cultured with sRANKL (20 ng/m l) alone for
5 days (left panel) or co-cultured with BIL-2 from day 2 to 5 (right panel) and stained for TRAP. Arrowheads indicate phagocytosed beads. On day
5, cells were stained for TRAP and photographed under an inverted-phase-contrast microscope (×100). B. RAW264.7 cells were cultured with various
amounts of sRANKL and IFN-γ. On day 5, cells were stained for TRAP and photographed under an inverted-phase-contrast microscope (×100).
 
F ig u re  4 . Neutralization of IFN-γ reversed the suppressive effect of BIL-2. Various amounts of anti-IFN-γ neutralizing mAb were added with BIL-2
cells from day 2 to 5 during 5 day-sRANKL-induced osteoclastogenesis. Data shown are a representative of two sim ilar results, mean and SEM
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sive factors such as IFN-γ (Figure 2A and 2B), and 
enhanced osteoclastogenesis (Figure 1). Abundant 
expression of RANKL and support of osteoclast differ-
entiation by B cells were recently reported by other 
investigators, too (Manabe et al., 2001). When we 
stained B cells with succinimidyl ester of carboxy-
fluorescein diacetate (CFSE) and co-cultured with 
RAW264.7 cells, none of the differentiated osteoclasts 
had fluorescence (data not shown), excluding the 
possibility that B cell themselves differentiate into 
osteoclasts as suggested from the shared lineage in 
these two cells (Sato et al., 2001). Compared with 
BTh2, BIL-2 expressed high levels of IFN-γ as well as 
RANKL, TNF-α, and TNF-β (Figure 2A). Induction of 
many giant cells by co-culture with BIL-2 suggested 
that IFN-γ had an important role in the inhibitory 
action, which was confirmed by the use of anti-IFN-γ 
neutralizing Ab (Figure 4). BIL-2 also expressed cyto-
kines that are known to antagonize IFN-γ mediated 
activation of macrophage: IL-4, IL-13, 1L-10, and 
TGF-β (Gazzinelli et al., 1992; Hausmann et al., 1994; 
Paludan et al., 1997; Paludan et al., 1998). However, 
none of these could reverse IFN-γ mediated inhibition 
of osteoclastogenesis. TNF-α that induces the ex-
pression of TRAF6 (Kaji et al., 2001; Zhang et al., 
2001) showed a slight antagonistic effect, but never 
reversed the inhibitory effect completely (Figure 5). 
These results suggested that: 1) IFN-γ uses different 
signal pathways in macrophages and osteoclasts; 2) 
IFN-γ is a key negative regulator of osteoclastogene-
sis even in the presence of RANKL, TNF-α and TNF-β.
  How BIFN-γ inhibited osteoclastogenesis is not clear 
at present. TGF-β might have a role as shown by 
Weitzmann et al., although the role of TGF-β in osteo-
clastogenesis is controversial (Weitzmann et al., 2000). 
Otherwise, cytokines that we did not analyze or un-
known factors produced by BIFN-γ may have played a 
role.
  In summary, we have demonstrated that Th2- 
dependent B cells and B cells activated in the pre-
sence of Th1 cytokines, IL-2 or IFN-γ, have opposite 
effects on osteoclastogenesis in vitro, acting positively 
and negatively, respectively. In addition, we have 
shown that IFN-γ is a key negative regulator of osteo-
clastogenesis that mediated the inhibitory effect of 
BIL-2 in the presence of two major osteoclast inducing 
factors, RANKL and TNF-α. Our findings suggested 
that activated B cells infiltrated into inflammation sites 
should not be regarded as cells of a uniform pheno-
type and Th1 cytokines might protect against bone 
destruction in an inflammatory bone disease such as 
periodontitis, acting directly on osteoclasts or indirectly 
through B cells.
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